12:50 PM EDT, 04/15/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target by $12 to $80, based on a 2026 P/E of 25.4x, a slight premium to KO's historic average multiples. Our adjusted EPS estimates are unchanged. We upgrade KO shares to Buy as the recent drop in the dollar relative to other major currencies should turn into a material bottom-line tailwind. KO generated 61% of its total revenue outside the United States last year, and U.S. revenue grew 11% Y/Y in 2024 (vs. a 2% decline for non-U.S.). Additionally, we view KO's fairlife brand as an underappreciated growth driver in the U.S. (annual sales have grown to $1B+), capable of helping drive above-average growth for KO's top and bottom lines over the next few years, particularly following a major capacity addition with completion of its new $650M fairlife plant in upstate New York by year-end. In our view, concerns related to "Make America Healthy Again" initiatives and tariffs are fully discounted at current levels and its dividend should augment KO's total return potential.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.